Epsilen Bio Company
Epsilen Bio is developing a transformative therapy known as Epigenetic Silencing to treat human diseases.
Industry:
PharmTech
Investors Number:
1
Technology:
Immunotherapy
Last Funding Type:
Seed
Headquarters:
Milan, Lombardia, Italy
Founded Date:
2019
Investor Type:
For Profit
Funding Status:
Seed
Employee Number:
1-10